Summary
CVS Health Corporation (CVS) has filed an 8-K report on July 10, 2020, primarily detailing amendments to its By-laws, effective immediately as of July 8, 2020. These changes are largely procedural and designed to update corporate governance mechanisms. Key revisions include modifications to advance notice provisions for director nominations and stockholder proposals, procedures for calling special meetings and acting by written consent, and clarifications on stockholder meeting conduct, including those held remotely. Furthermore, the Amended and Restated By-laws introduce provisions for special Board meetings with less than two days' notice and establish emergency by-laws. These emergency by-laws empower the Board to operate with reduced procedural requirements and take necessary actions during emergency conditions. While these changes are significant for corporate governance, they do not appear to directly impact the company's financial performance or strategic operations as of the filing date.
Key Highlights
- 1CVS Health Corporation's Board of Directors approved amended and restated By-laws on July 8, 2020.
- 2The amendments update and revise advance notice provisions for director nominations and stockholder proposals.
- 3Procedures for stockholders to call special meetings and act by written consent have been revised.
- 4Clarifications have been made regarding stockholder meeting procedures, including remote participation.
- 5The By-laws now allow for special Board meetings with less than two days' notice.
- 6Emergency by-laws have been added to enable the Board to operate with reduced procedural requirements during emergencies.
- 7The filing includes the full text of the Amended and Restated By-laws as an exhibit.